Homoeopathy for Vitiligo

Not yet recruiting

• Conditions: Vitiligo,

• Registration Number: CTRI/2022/03/041296
• Lead Sponsor: Dr Neha Singhal

Brief Summary

This study is an open label, prospective, uncontrolled clinical trial for evaluating the effectiveness of individualised homoeopathic medicine in the treatment of vitiligo. The homoeopathic medicine will be administered in centesimal scale, each dose shall consist of 6-8 globules of cane sugar, moistened with the indicated medicine to be taken orally on clean tongue; dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP) certified firm. The outcomes will be assessed initially at the baseline and every month upto 1 year.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-03-21
• Study Start: 2022-03-28

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients suffering from vitiligo.

Exclusion Criteria

Cases with other auto-immune disorders.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Size of skin lesion.	Intially at the baseline then every month upto 1 year.

Secondary Outcome Measures

Name	Time	Method
VASI score.
VitiQol questionnaire.	Initially at the baseline then every month upto 1 year.
Skindex-16 questionnaire.	Initially at the baseline then every month upto 1 year.
DLQI questionnaire.	Initially at the baseline then every month upto 1 year.

Trial Locations

Locations (1)

Nehru homoeopathic medical College and hospital; 🇮🇳 South, DELHI, India

Nehru homoeopathic medical College and hospital

🇮🇳South, DELHI, India

Dr Neha Singhal

Principal investigator

8287684579

nehasinghal1208@gmail.com